President’s Award for Outstanding Contribution to Global Health
The mission of the TB Alliance is to help foster the creation of faster acting tuberculosis (TB) drugs and eventually find a cure for TB. TB Alliance was conceived at a February 2000 meeting in Cape Town, South Africa, where 120 representatives from academia, industry, major agencies, non-governmental organizations, and donors gathered to discuss the need for new TB treatments. At the time, there were no TB drugs in clinical development and, therefore, little hope for better cures. Participants stressed the need for new TB drugs, highlighted the unprecedented scientific opportunities, and underscored the lack of market incentive for pharmaceutical companies to develop new TB treatments.